UNSPSC 51162309: Acetaminophen/chlorpheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162309 Acetaminophen/chlorpheniramine is a Commodity code that in recent state and local solicitations covers parenteral pharmaceutical products, intravenous solutions, and emergency medical supplies rather than the acetaminophen/chlorpheniramine combination reflected in the code name. The Washington State Department of Corrections (DOC) RFQ RFQQK13020, posted September 8, 2026 with responses due October 7, 2026, solicits parenteral nutrition solutions (TPN and PPN), intravenous fluids, and controlled substances for eight correctional facilities across Washington state, requiring 24-hour delivery of PN bags and 8-hour delivery of other parenteral products. Issuing bodies include state departments of corrections and county health agencies; the Washington DOC opportunity emphasizes participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under state set-aside goals, with primes required to develop Subcontractor Inclusion Plans naming qualified diverse subcontractors where economically prudent.

Washington state and Florida show recent activity under this code. The Washington DOC anticipates awarding up to three contractors per region (West, Central, and East) with an initial contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the first two years. A secondary opportunity, Seminole County, Florida IFB 60459723LAS (posted June 30, 2026, due July 26, 2023), procures naloxone and drug deactivation systems with quarterly deliveries to the county community health building; however, this opportunity appears mistagged under the acetaminophen/chlorpheniramine code and does not reflect the parenteral pharmaceutical focus of the code's primary recent activity. The Washington DOC solicitation represents the most aligned recent opportunity, reflecting genuine state demand for parenteral products and services to correctional healthcare systems.